Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$1.81M Buy
+30,525
New +$1.76M 2.52% 2
2015
Q2
$5.25M Sell
78,165
-4,840
-6% -$316K 2.45% 2
2015
Q1
$4.86M Buy
83,005
+27,330
+49% +$1.65M 2.11% 2
2014
Q4
$3.64M Buy
55,675
+17,495
+46% +$1.1M 1.46% 11
2014
Q3
$2.21M Sell
38,180
-16,575
-30% -$920K 1.08% 37
2014
Q2
$3.09M Sell
54,755
-400
-0.7% -$21K 1.21% 24
2014
Q1
$2.83M Buy
55,155
+650
+1% +$32.9K 1.15% 24
2013
Q4
$2.88M Buy
54,505
+800
+1% +$39.3K 1.19% 23
2013
Q3
$2.4M Buy
53,705
+15,325
+40% +$679K 1.09% 28
2013
Q2
$1.59M Buy
+38,380
New +$1.68M 0.92% 44

Other funds holding ABBV

Semper Trust's ABBV Position: Q4 2015 in Review

Semper Trust opened a new position in AbbVie (ABBV) in Q4 2015: 30,525 shares worth $1.81M. The stake represents 2.52% of the portfolio and ranks #2 among its holdings. This is a return to the name: Semper Trust previously reported a position in ABBV as recently as Q2 2015.

Semper Trust first reported a position in ABBV in Q2 2013 and has held it in 10 quarters since. The position peaked at $5.25M in Q2 2015. 1,636 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

  • Semper Trust held 30,525 shares of AbbVie worth $1.81M as of Q4 2015.
  • AbbVie was a new Semper Trust position in Q4 2015.
  • AbbVie made up 2.52% of Semper Trust's portfolio in Q4 2015, its #2 holding.
  • Semper Trust first reported a position in AbbVie in Q2 2013 and has held it in 10 quarters since.
  • Semper Trust's AbbVie position peaked at $5.25M in Q2 2015.
  • 1,636 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Semper Trust's 13F filing for Q4 2015, filed 11 Feb 2016.